Ginger Milne

Professor innovating in the area of molecular medicine, Ginger Milne, Ph.D., serves as a Research Associate Professor of Medicine at Pharmacology Vanderbilt University. Her research is primarily focused on unraveling the molecular mechanisms that underpin neurodegenerative diseases, as well as exploring the role of oxidative stress in cardiovascular and pulmonary diseases. Dr. Milne has made significant strides in the field by developing and characterizing a novel family of bioactive compounds known as cyclopentenone prostaglandins and isoprostanes. These compounds are produced through the free radical-catalyzed peroxidation of unsaturated fatty acids. Her work has illuminated the diverse and sometimes opposing biological properties of these compounds, which play crucial roles in various physiological and pathophysiological processes, including inflammation, cell death, and tissue remodeling. Her research has provided valuable insights into how oxidative stress contributes to the progression of cardiovascular and pulmonary diseases, offering potential pathways for therapeutic intervention. Dr. Milne's work is characterized by a deep commitment to understanding the complex interplay of biological processes that lead to disease, with the ultimate goal of identifying novel targets for treatment. In addition to her research, Dr. Milne is dedicated to mentoring the next generation of scientists, fostering an environment of inquiry and innovation. Her contributions to the field have been recognized through numerous publications and presentations at national and international conferences. Dr. Milne continues to push the boundaries of medical research, with her work promising to pave the way for new therapeutic strategies in the treatment of debilitating diseases. Her dedication to advancing our understanding of disease mechanisms underscores her role as a leader in the field of pharmacology and medicine.